Neither peptide has received regulatory approval as a therapeutic agent from the FDA, EMA, or other major regulatory bodies
Unger, Ketterer, Dupr, Eisentraut
Side effects can often be minimized by following the recommended dosage escalation schedule, staying well hydrated, eating smaller meals, and avoiding high-fat foods during dose increases
[1] [3] For multi-dose pens that require priming, follow your specific product's IFUsome require priming only before first use, while others have different instructions
Patients with MEN 2 have substantially elevated lifetime risk of developing MTC, often at younger ages
They often offer 90-day supplies, which can be cheaper per dose